November 25, 2016- What if, as part of your routine well visit to your primary care physician, you could track your predispositions – genetic and otherwise – for developing cancer?
The idea of routine preventive care for cancer is something CancerIQ co-founder and CEO Feyi Olopade ’01 is working to make a reality.
Olopade founded the company in 2014 with her mother, renowned breast cancer doctor Funmi Olopade. Feyi’s background includes business school at Wharton and stints in investment banking and private equity. Eager to combine her entrepreneurial spirit with a social impact issue, the younger Olopade partnered with her mother to develop CancerIQ, a clinical decision support tool that helps physicians identify potential risk factors for their patients and arms those patients with the personal healthcare options necessary to intervene.
